Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,256 signal articles · 54 in last 24h · 115,224 total before filter · latest 50m ago
54last 24h
1814last 7d
298● bullish (7d)
171● bearish (7d)
205publishers
AllMacro323Earnings860M&A105Regulatory25Product16Analyst25
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Coinbase beats much of customer lawsuit over US token sales
Reuters16d agobullish
Coinbase beats much of customer lawsuit over US token sales

NEW YORK, July 30 (Reuters) - Coinbase won the dismissal on Thursday of much of a lawsuit in which customers accused the largest U. ‌cryptocurrency exchange of illegally selling securities without registering as an exchange or ‌broker-dealer.

FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System
Benzinga22d agobullish
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System

The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing clearance encompasses multiple general surgery...

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC
Insider Monkey48d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]

AI stock surges amid multi-million-dollar lawsuit
TheStreet53d agobullish
AI stock surges amid multi-million-dollar lawsuit

Shares of Hut 8 (NASDAQ: HUT) tumbled in the pre-market session on June 22 but recovered lost ground after the morning bell. The stock fell about 7% to $112.50 after closing the prior day down 2.73% at $121.04. But at press time, the shares were trading 2.36% higher inraday and trading near ...